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Human tumours which grow and metastasize in
immunodeficient animals are amenable to con-
trolled investigation of human tumour metastasis in
the presence of the original tumour inoculum. In
previous reports (Ware et al., 1982, 1984), we
described a unique human prostate carcinoma
subline, l-LN-PC-3-lA, which consistently
metastasizes from a subcutaneous (s.c.) site to both
regional and distant lymph nodes in tumour-excised
adult athymic nude mice. These tumour cells also
form multiple lung micrometastases in 30-50% of
tumour-excised mice (Ware et al., 1984).
We have used this model system to address two
basic questions concerning spontaneous metastasis
of the human prostate carcinoma subline 1-LN-PC-
3-lA growing subcutaneously in adult nude mice:
(i) What are the characteristics of metastasis by
these cells in the presence of the original s.c.
tumour, and (ii) Is the size of the s.c. tumour a
significant determinant of lymphatic metastasis in
this experimental system?
Male athymic nude mice (nu/nu) (BALB/
cAnBOM), 6-8 weeks old, were used in all experi-
ments. Specific pathogen-free mice were obtained
from two sources. Groups 1 and 2 were purchased
from Harlan-Sprague Dawley (Indianapolis,
Indiana). These mice were received from the
supplier at the age of 4-5 weeks and allowed to
acclimatize for 2 more weeks in a barrier facility
prior to any experimentation. Groups 3 and 4 were
obtained from the breeding colony of athymic nude
mice maintained by the Urology Research
Laboratories, Duke University Medical Center. All
of these mice (groups 1, 2, 3 and 4) were provided
with sterile food, water, bedding and cages, and
maintained in an isolated barrier facility with strict
access limitations. Heterozygous (nu/+) mice were
maintained under the same conditions as the
experimental animals to act as additional monitors
for microbial contamination. No evidence of
nonspecific bacterial contamination or parasitic
infection was found for mice involved in these
experiments. Furthermore, sera from the
heterozygous sentinal mice were screened by the
Veterinary Diagnostic Laboratory, University of
Missouri School of Veterinary Medicine
(Columbus, Missouri) and found to be free of
significant titres of antibody to any of the 11 most
common murine viruses, including murine hepatitis
virus.
The utilization of mice from 2 different suppliers
served two functions. It allowed inclusion of
sufficient numbers of nude mice in each group to
permit meaningful statistical analysis and it also
ensured that the results obtained would not be
unique to mice from a single source. The mice were
divided into 4 chronologically spaced groups, 2
from each supplier, in an effort to eliminate time
and batch biases and thus to allow identification of
effects which would be general across time.
Human prostate carcinoma cells designated 1-
LN-PC-3-IA were derived from a spontaneous
lymph node metastasis originating in a nude mouse
bearing a PC-3-IA tumor as described previously
(Ware et al., 1982). PC 3-lA (Ware et al., 1982)
was obtained from the established human prostate
carcinoma cell line PC-3 (Kaighn et al., 1979). Cells
used in these experiments were recovered from
frozen stocks stored in liquid nitrogen and
maintained in vitro no more than 3 weeks prior to
injection. These cells were grown in RPMI 1640
supplemented with 10% heat-inactivated calf serum
(HYCLONE Laboratories, Logan, Utah) and
gentimicin (50mg1-1). All cells were free of
mycoplasma contamination as revealed by
cytoplasmic staining with quiniquine dihydro-
chloride. Cells were collected by gentle scraping
with a sterile rubber policeman and were .95%
viable by trypan blue exclusion.
Groups of mice were injected s.c. with 106 1-LN
cells in a volume of 0.2ml PBS on the lower left
dorsal surface. Mice were randomized to be
sacrificed 21, 26, 31 or 36 days after the initial s.c.
injection. Tumours grew s.c. in 100% of the
injected animals and were measurable 9 days after
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injection. Growth of the s.c. tumour was monitored
3 times a week by measurement with vernier
calipers. The volume of the s.c. tumour was
calculated by the following formula:
Ix V=2
2
where 1=length and w=width. This geometric
formula for approximate calculation of the volume
of an ellipsoid is commonly used to estimate s.c.
tumour volume from linear dimensions with
reasonable accuracy (Steele, 1977; Norton & Simon,
1979). The tumours described in this study
appeared to grow as prolate spheroids during the
exponential phase of growth and the tumour
volumes used in this analysis were measured during
that phase.
The average s.c. tumour volume doubling time
was 3.5 days. On the day of sacrifice, the s.c.
tumour was removed and weighed. The site of the
original tumour inoculum, designated "primary",
was examined for gross evidence of invasion of
muscle or the peritoneal membrane. At autopsy the
left and right inguinal lymph nodes, the axillary
lymph nodes, and the brachial lymph nodes were
removed and preserved in 10% buffered formalin.
Any grossly enlarged internal lymph nodes, as well
as the lungs, were also removed and preserved for
histological examination.
Lymph nodes were embedded in paraffin and
semi-serially sectioned (5 ym thickness) at 80,m
intervals. Lungs were subjected to routine
sectioning procedures which had previously dis-
closed multiple lung micrometastases in tumour-
excised mice (Ware et al., 1984). All tissues were
stained with hematoxylin and eosin. Micro-
metastases were defined as a focus of 20 or more
tumour cells detected in a 5 ym section. Lymph
nodes removed from mice later than 21 days
after injection often contained hundreds of tumour
cells which displaced half of the normal lymphoid
architecture.
In order to determine which variables signifi-
cantly influenced development of micrometastases,
logistic regression analyses were performed. This
type of analysis models the probability of response
(in this case, development of histologically
detectable metastases) as a logistic function of the
variables considered. This approach is commonly
used in bioassay experiments (Finney, 1978). To
evaluate whether other effects were being
confounded by sacrifice time, we performed all
analyses with and without controlling for time of
sacrifice. Linear contrasts were used to detect
effects due to different sacrifice times (Steel &
Torrie, 1980).
The 1-LN-PC-3-lA cells consistently metastasized
to the superficial lymph nodes of adult athymic
nude mice in the presence of the original s.c.
tumour. Both regional and distant lymphatic
metastases were observed among these mice.
Internal lymph node metastases were also found in
mice sacrificed at 31 or 36 days. Furthermore,
internal lymphatic metastases were present in some
mice which were free of superficial lymphatic
metastases. Three mice sacrificed at day 31 and two
mice sacrificed at 36 days had enlarged renal and/or
paraaortic lymph nodes with histologically
confirmed metastases. However, all superficial
lymph nodes, including the ipsilateral inguinal
lymph node, were free of micrometastases. Lung
micrometastases were rarely found during routine
sectioning (1/8 mice sacrificed 36 days after s.c.
injection). Only 4/58 mice examined had s.c.
tumours which were macroscopically invasive at
autopsy.
As indicated in Table I, for the combined data
from groups 1, 2, 3 and 4, 11/15 (73%) mice
sacrificed 21 days after injection had 1 or more
lymphatic metastases, while 9/18 (50%) mice had
micrometastases at day 26. Among mice sacrificed
31 and 36 days after injection, metastases were
detected in 12/17 (71%) and 7/8 (88%) respectively.
The logistic regression analysis indicated no
significant difference in probability of metastases
due to time of sacrifice (P=0.27). However, in a
preliminary analysis of groups 1, 2 and 3, a
pronounced reduction in incidence of metastases
was noted at day 26. Linear contrasts on this effe-t
pinpointed a barely significant (P=0.05) decrease
in percentage of mice with metastases between days
21 (75%) and 26 (36%), followed by an increase
(P=0.06) from day 26 to day 31 (71%). The mean
number of lymph node metastases per mouse was
Table I Proportion of tumour-bearing mice with
lymphatic metastases at different times after injection
No. ofmice with lymphatic metastases/
no. ofmice sacrificed at the indicated day
after injection
Group 21 26 31 36
1 2/3 2/5 4/5 3/3
2 3/3 2/5 2/5 3/3
3 4/6 1/4 4/4 1/2
4 2/3 4/4 2/3 ND
Total 11/15 9/18 12/17 7/8
(% All) (73%) (50%) (71%) (88%)
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1.3, 1.0, 1.5 and 1.4 for mice sacrificed on days 21,
26, 31, and 36 respectively.
Macroscopically visible lymphatic metastases
were not observed until 26 days after injection in
any mice. The development of macrometastases
increased in parallel to the increase in micro-
metastases from days 26 to 36 (Figure 1).
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Figure 1 Comparison of percentage of nude mice
with histologically detected lymphatic micrometastases
(0) with percentage of nude mice also having
macrometastases (0) of the lymph nodes. (Combined
data. groups 1, 2, 3 and 4. See Table I).
In general, the size of s.c. tumour correlated
positively with the probability of lymphatic
metastasis, i.e., the.larger the tumour, the greater
the likelihood of lymphatic metastasis. The most
influential variable in our analyses was tumour
volume 20 days after s.c. injection (VOL20).
Regardless of which combinations of variables were
modeled, VOL20 consistently emerged as a
statistically significant predictor of tumour
metastases, with higher volume yielding higher
probabilities of metastases (Table II). Tested alone
in the model using the combined data from groups
1, 2, 3, and 4, VOL20 had a P-value of 0.004; after
controlling for day of sacrifice, the P-value
remained at 0.006. Furthermore, the effect was
consistent over the four sacrifice dates (i.e., there
was not a statistically significant, nor visually
evident, interaction effect between this variable and
day of sacrifice). Volume measured on Day 9 also
correlated positively with the probability of
metastasis, but was less significant statistically
(P=0.07). The greater significance of s.c. volume
calculated at Day 20 may have reflected greater
accuracy in caliper measurements. Nine days post-
injection was the earliest date at which the s.c.
tumours were measurable, and accurate length and
width measurements were more difficult to obtain
at Day 9, thus contributing to greater potential
error in volume calculations.
The weight of the s.c. tumour at the time of
sacrifice also had a positive influence on
development of metastases (P =0.03 alone and
P=0.02 after controlling for sacrifice time) (Table
III). This result is consistent with the finding for
volume at day 20, since tumour weight and volume
are highly correlated. In fact, among those mice
sacrificed at Day 21, the correlation between
volume at Day 20 and sacrifice weight was 0.85
(P=0.0001).
The relation between specific growth parameters
of a primary tumour and its metastases may be
positive, negative, or nonexistent, depending upon
the host/tumour system examined. The metastatic
behaviour of several animal tumours has been
shown to be influenced by the presence or absence
(Gorelik, 1983), size (Anderson et al., 1974), and/or
growth rate (Dewys, 1972) of the primary tumour.
Table II Effect of s.c. tumour volume on lymphatic metastases in tumour-bearing
mice
Groups 1, 2, 3 and 4
Day ofsacrifice
21 26 31 36
Incidence of metastases
(from Table I) 11/15 9/18 12/17 7/8
Mean volume Day 20 (±s.d.)
(mm3) for:
Mice without metastases 212 (±51) 253 (±86) 229 (±117) 224a
Mice with metastases 387 (± 172) 348 (± 195) 366 (± 111) 300 (±85)
Significance of volume at Day 20 as a predictor of lymphatic metastasis: P=0.004.
aIndicates only one mouse in this category, therefore no s.d. possible.422 J.L. WARE & E.R. DELONG
Table III Effect of s.c. tumour weight at date of sacrifice on lymphatic metastases in
tumour-bearing mice
Groups 1, 2, 3 and 4
Day ofsacrifice
21 26 31 36
Incidence of metastases
(from Table I) 11/15 9/18 12/17 7/8
Weight (g) (±s.d.):
Mice without metastases 0.220 (±0.08) 0.710 (±0.29) 0.570 (±0.23) li.la
Mice with metastases 0.390 (±0.19) 0.770 (±0.40) 1.47 (±0.65) 1.54 (±0.87)
Significance of s.c. tumour weight at day of sacrifice as a predictor of lymphatic metastases:
P=0.03.
aIndicates only one mouse in this category, therefore no s.d. possible.
In other cases, no correlation between growth rate
(Hager et al., 1978) or primary tumour size (Price
et al., 1982) and metastatic incidence has been
observed. The influence of the size of a human
tumour on metastatic behaviour in immunodeficient
hosts is relatively unexplored. The reproducible
lymphatic metastases by l-LN-PC-3-IA cells in
tumour-bearing nude mice provided the
opportunity to analyze the relation between s.c.
tumour size and the probability of metastases for
this human prostate tumour. Furthermore, this
study demonstrated the important role of statistical
methods in the design and analysis of this type of
biological experiment.
Using logistic regression analyses, we demon-
strated that the size of the s.c. tumour correlated
positively with the probability of lymphatic
metastasis among these 58 nude mice. The most
influential variable was the calculated s.c. tumour
volume 20 days after inoculation. After controlling
for time (day of sacrifice), VOL20 was still a
significant factor. Thus s.c. tumour size, rather than
duration of growth, appeared to be the important
parameter. Furthermore, the weight of the s.c.
tumour at the day of sacrifice also had a positive
influence on development of metastases. Thus the
findings for two different expressions of tumour
size were consistent with each other.
We believe that our randomized design enhances
the significance of these results. Immediately after
tumour inoculation, each mouse received a
randomly generated sacrifice time (21, 26, 31, or 36
days). Thus no subconscious bias could have led us
to consistently sacrifice mice with certain attributes,
e.g., large tumours, either early or late in the
schedule.
We also believe that our statistical analysis is the
appropriate one for this study design. Rather than
comparing results obtained at individual sacrifice
days separately, we have incorporated data for all
sacrifice days into a unified analysis. We have thus
enhanced the power of analysis while decreasing the
number of statistical tests performed.
The mean number of metastases per mouse was
relatively constant, 1-2 per mouse. This contrasts
with previous investigations of the l-LN-PC-3-lA
line in tumour-excised nude mice. Among mice
sacrificed 4 weeks after tumour excision (8 weeks
post-injection), multiple lymph node metastases
were often found per mouse and lung micro-
metastases were demonstrable in half the mice in
routine lung sections (Ware et al., 1984; Ware,
unpublished observations). These experiments are
not strictly comparable to the ones described in this
report due to temporal differences. Nonetheless, the
rarity of pulmonary micrometastases and the
restriction of the number of lymphatic metastases
per mouse among tumour-bearing mice were
striking. This apparent difference in metastatic
dissemination between tumor-excised and tumour-
bearing mice has been observed by other
investigators working with human tumours grown
in nude mice. The excision of several human
melanomas (Wilson et al., 1980), human breast
carcinomas (Ozzello & Sordat, 1980), and human
colon carcinoma cells (Sordat et al., 1982) growing
s.c. is reported to promote or permit greater
dissemination of these tumours in adult nude mice.
As a variation on approaches taken by other
investigators, we chose to begin analyzing the
relation between the size of a human tumour and
its metastases in nude mice without disturbing (i.e.,HUMAN TUMOUR SIZE AND METASTASIS IN NUDE MICE 423
excising) the s.c. tumour. Application of statistical
methodology in both experimental design and
interpretation of the data permitted identification of
a positive correlation between s.c. tumour size and
the probability of lymphatic metastasis by the
human prostate carcinoma cells, 1-LN-PC-3-lA.
This finding provides a foundation for future
experimental analysis of the mechanisms underlying
this size-metastasis relation for a human tumour
growing in a nude mouse.
This research was supported by NCI grant CA33208,
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